ERASCA INC's ticker is and the CUSIP is 29479A108. A total of 89 filers reported holding ERASCA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,843,668 | -27.5% | 7,027,243 | +1.6% | 0.00% | -100.0% |
| Q2 2023 | $19,091,345 | +18.1% | 6,917,154 | +28.8% | 0.00% | – |
| Q1 2023 | $16,169,265 | -24.9% | 5,371,849 | +7.6% | 0.00% | -100.0% |
| Q4 2022 | $21,522,188 | -42.4% | 4,993,547 | +4.3% | 0.00% | 0.0% |
| Q3 2022 | $37,345,000 | +57.7% | 4,787,793 | +12.6% | 0.00% | 0.0% |
| Q2 2022 | $23,687,000 | -28.5% | 4,252,373 | +10.4% | 0.00% | 0.0% |
| Q1 2022 | $33,114,000 | +12.5% | 3,850,410 | +103.9% | 0.00% | 0.0% |
| Q4 2021 | $29,422,000 | +14.7% | 1,888,445 | +56.2% | 0.00% | 0.0% |
| Q3 2021 | $25,651,000 | – | 1,208,816 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 11,055,554 | $21,779,441 | 14.15% |
| EDBI Pte Ltd | 888,888 | $1,751,109 | 1.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,926,000 | $3,794,220 | 1.28% |
| Cormorant Asset Management, LP | 10,813,246 | $21,302,095 | 1.24% |
| AH Equity Partners LSV II, L.L.C. | 312,500 | $615,625 | 0.64% |
| Artal Group S.A. | 4,721,194 | $9,301 | 0.40% |
| PFM Health Sciences, LP | 3,930,633 | $7,743,347 | 0.36% |
| ARMISTICE CAPITAL, LLC | 8,356,000 | $16,461,320 | 0.25% |
| SANDERS MORRIS HARRIS LLC | 425,297 | $816,569 | 0.17% |
| Prosight Management, LP | 264,710 | $521,479 | 0.16% |